Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended p_{3/2} Neutron Orbital and the N=32 Shell Closure in ^{52}Ca.

Physical review letters·2023
Same author

Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases.

Seminars in nuclear medicine·2021
Same author

Pairing Forces Govern Population of Doubly Magic ^{54}Ca from Direct Reactions.

Physical review letters·2021
Same author

Two-Neutron Halo is Unveiled in ^{29}F.

Physical review letters·2020
Same author

Ionising radiation exposure from medical imaging - A review of Patient's (un) awareness.

Radiography (London, England : 1995)·2020
Same author

Quasifree Neutron Knockout from ^{54}Ca Corroborates Arising N=34 Neutron Magic Number.

Physical review letters·2019
Same journal

Exploring the Need for Plan Adaptation in Robustly Optimised Head and Neck Intensity Modulated Proton Therapy: A Dosimetric Perspective From Initial Institutional Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Lifting the Lid on Best Practice in a Case of Oligometastatic Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Standardisation of Imaging Surveillance for Patients With Metastatic Melanoma Stopping Immune Checkpoint Inhibitors.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Valuing Public Sector Data Assets: Methodological Perspectives From the Add-Aspirin Trial's Use of Healthcare Systems Data for Clinical Follow-Up.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Autologous Cell Therapy in Oncology: Current Landscape and Future Directions.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Proton Beam Therapy for Intracranial Germ Cell Tumors in Pediatric, Adolescent, and Young Adult Patients: A Single-Center Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
See all related articles

Related Experiment Video

Updated: Nov 24, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.6K

Systemic Radiotherapy of Bone Metastases With Radionuclides.

I Murray1, Y Du2

  • 1Joint Department of Physics, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|December 23, 2020
PubMed
Summary
This summary is machine-generated.

Radionuclide therapies, including strontium-89 and samarium-153 ethylenediaminetetramethylene phophanate (EDTMP), effectively palliate bone metastasis pain. Radium-223 shows promise for metastatic castrate-resistant prostate cancer, with ongoing research into targeted radiopharmaceuticals.

Keywords:
Bone metastasesPSMAradium-223samarium-153strontium-89

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.5K
Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound
12:23

Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound

Published on: August 14, 2012

14.6K

Related Experiment Videos

Last Updated: Nov 24, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.6K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.5K
Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound
12:23

Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound

Published on: August 14, 2012

14.6K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiopharmaceutical Therapy

Background:

  • Radionuclide therapy is an established oncologic treatment for bone metastases.
  • The field is continuously evolving with new therapeutic agents and strategies.
  • Existing treatments aim to alleviate pain and improve patient outcomes.

Purpose of the Study:

  • To review the evidence supporting the use of strontium-89 and samarium-153 ethylenediaminetetramethylene phophanate (EDTMP) for bone metastasis pain palliation.
  • To examine the evidence for radium-223 in treating metastatic castrate-resistant prostate cancer.
  • To discuss advancements in optimizing radionuclide treatments and developing novel targeted radiopharmaceuticals.

Main Methods:

  • Review of clinical evidence for approved radiopharmaceuticals (strontium-89, samarium-153 EDTMP, radium-223).
  • Discussion of strategies for treatment optimization, including dose escalation and combination therapies.
  • Overview of emerging radiopharmaceutical development targeting specific cancer biomarkers.

Main Results:

  • Strontium-89 and samarium-153 EDTMP are approved and effective for bone metastasis pain palliation.
  • Radium-223 has demonstrated efficacy in metastatic castrate-resistant prostate cancer.
  • Research is exploring methods to enhance treatment efficacy and patient response rates.

Conclusions:

  • Radionuclide therapy remains a vital component in managing bone metastases.
  • Ongoing research focuses on improving existing treatments and developing targeted therapies, such as those targeting prostate-specific membrane antigen.
  • Future directions include optimizing radiation delivery and combining radionuclide therapy with other treatment modalities.